SEC Filing Summary: SIGA Technologies, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SIGA Technologies, Inc. (SIGA) on June 13, 2006, covering events occurring on June 9, 2006. SIGA is a Delaware corporation headquartered in New York. The filing primarily addresses a significant corporate development involving a merger agreement.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the announcement of a corporate transaction rather than periodic financial performance.
Material Changes
The material change reported is the execution of a definitive agreement for the merger of PharmAthene, Inc. and SIGA Technologies, Inc. The agreement was dated June 8, 2006, and involves SIGA, PharmAthene, and SIGA Acquisition Corp., a wholly owned subsidiary of SIGA. A joint press release was issued on June 9, 2006, to announce this transaction.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies within the body of the text. The document references a joint press release (Exhibit 99.1) and a previously filed Form 8-K containing the Agreement and Plan of Merger for further details on the transaction terms.
Key Facts for Investor Verification
- Transaction Type: Definitive merger agreement between SIGA and PharmAthene.
- Transaction Date: Agreement dated June 8, 2006; announced June 9, 2006.
- Structural Details: The merger involves SIGA Acquisition Corp., a wholly owned subsidiary of SIGA.
- Documentation: The full Agreement and Plan of Merger is available as an exhibit to a SIGA Form 8-K filed on June 13, 2006.
- Financial Data: No financial performance data is included in this specific filing; investors must refer to the referenced press release and merger agreement for deal terms.